Volume 38 • Number 6JUNE 2008
Pharmacogenetics
This issue of Psychiatric Annals provides reviews of the pharmacogenetics of such drugs as lithium, antidepressants, anticonvulsants, and naltrexone for the treatment of alcohol addiction.
Editorial
The Dream of Pharmacogenetics
Jan Fawcett, MD
From the Guest Editor
Pharmacogenetics
Wade Berrettini, MD, PhD
Psychiatry in the News
Defining the Role of Anti-epileptic Pharmacogenetics in Psychiatric Drug TherapyDennis J. Dlugos, MD; Russell J. Buono, PhD; Thomas N. Ferraro, PhD
Pharmacogenetics of Lithium ResponseCristiana Cruceanu, BSc; Catalina Lopez de Lara, MD; Martin Alda, MD; Gustavo Turecki, MD, PhD
Naltrexone Pharmacogenetics in Alcohol-dependent PatientsWade Berrettini, MD, PhD
Pharmacogenetics of Major Depressive DisorderFalk W. Lohoff, MD
See these other publications from SLACK Incorporated